Researchers at University of Utah Health and Harvard Medical School have discovered that bacteria detect invading viruses when a viral enzyme cuts a crucial sensor molecule, triggering an immune response that sacrifices the infected cell to protect its neighbors. The finding, published in October in the journal Science, uncovers a mechanism behind the CBASS antiphage defense system and provides a blueprint for engineering better bacteriophage therapies against antibiotic-resistant bacteria.
How Bacterial Proteases Detect Viral Threats
The research focuses on the CBASS defense system, which operates as a last-resort immune response in bacteria. When activated, the system rapidly kills the host bacterium to prevent viral replication and subsequent spread to adjacent cells. Because the consequence of this pathway is fatal for the host, precise detection of the viral trigger remains essential.
Sam Hobbs, assistant professor of biochemistry at University of Utah Health and first author of the study, explained that the sensing mechanism targets molecules essential for virus survival. Certain bacteriophages deploy proteins known as proteases to degrade other proteins. According to the study, the protease from the phage acts directly on a host protein, and that cleavage event serves as the signal that turns on the entire signaling pathway.
“This is one of the most common forms of bacterial immunity, so when we finally figured it out, it was a total eureka moment,” Hobbs said.
Evolutionary Conservation of Immune Pathways
The signaling pathways discovered in bacteria share similarities with those found in human immune systems. This evolutionary conservation suggests that fundamental mechanisms for detecting viral pathogens have remained intact across billions of years of evolution.
“The fact that these systems are conserved between bacteria and humans suggests that they’ve been maintained in these different organisms for that entire evolutionary trajectory,” Hobbs noted. “The cells are telling us that this is a really important pathway because they’ve maintained it for billions of years.”
The study, titled “Phage proteases activate CBASS antiphage immunity,” was co-authored by Philip J. Kranzusch, a professor of microbiology at Harvard Medical School. Understanding these detection methods allows researchers to design synthetic or modified phages capable of evading bacterial defenses, overcoming a hurdle in clinical phage therapy development.
Common Questions About Bacterial Immunity and Phage Therapy
What is a bacteriophage?
A bacteriophage, or phage, is a group of viruses that specifically target and infect bacteria. They can kill dangerous bacterial strains while leaving human cells unharmed, making them valuable candidates for treating antibiotic-resistant infections.
What does the CBASS system do in bacteria?
CBASS functions as a last-resort immune defense mechanism. When a bacterium detects a viral infection through this pathway, the system triggers cell death to halt viral replication before the infection can spread to neighboring bacterial cells.
How do phages trigger the bacterial immune response?
Researchers discovered that certain phages use enzymes called proteases that cut specific host proteins inside the bacterium. This cleavage acts as the precise trigger that activates the cell’s immune signaling pathway.
Where was the research published?
The findings were published on Oct. 1 in the journal Science under the title “Phage proteases activate CBASS antiphage immunity,” with researchers from University of Utah Health and Harvard Medical School participating in the study.
Related reading